Meaningful Symptoms of Immune Checkpoint Inhibitor Therapy-Related Gastrointestinal Adverse Events in Patients With Inflammatory Bowel Disease

被引：2

作者：

Inagaki, Yuji ^{[1
]}

Azuma, Kouji ^{[1
]}

Nakamura, Yukihiro ^{[1
]}

Kouno, Shunichi ^{[1
]}

Matsuda, Yoshinobu ^{[2
]}

Atagi, Shinji ^{[3
]}

机构：

[1] Kinki Chuo Chest Med Ctr, Natl Hosp Org, Dept Internal Med, Sakai, Osaka, Japan

[2] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Psychosomat Internal Med, Sakai, Osaka, Japan

[3] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

COLITIS;

D O I：

10.1200/JCO.20.00033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1748 / +

页数：3

共 50 条

[41] Rheumatologic immune checkpoint inhibitor-related adverse events
Defoe, Melissa
Bermas, Bonnie L.
CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (03) : 141 - 148
[42] Immune checkpoint inhibitor-related dermatologic adverse events
Geisler, Amaris N.
Phillips, Gregory S.
Barrios, Dulce M.
Wu, Jennifer
Leung, Donald Y. M.
Moy, Andrea P.
Kern, Jeffrey A.
Lacouture, Mario E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1255 - 1268
[43] Immune checkpoint inhibitor-related cutaneous adverse events
He, Chunxia
Qu, Tao
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (05) : E149 - E153
[44] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Schneider, Bryan J.
Naidoo, Jarushka
Santomasso, Bianca D.
Lacchetti, Christina
Adkins, Sherry
Anadkat, Milan
Atkins, Michael B.
Brassil, Kelly J.
Caterino, Jeffrey M.
Chau, Ian
Davies, Marianne J.
Ernstoff, Marc S.
Fecher, Leslie
Ghosh, Monalisa
Jaiyesimi, Ishmael
Mammen, Jennifer S.
Naing, Aung
Nastoupil, Loretta J.
Phillips, Tanyanika
Porter, Laura D.
Reichner, Cristina A.
Seigel, Carole
Song, Jung-Min
Spira, Alexander
Suarez-Almazor, Maria
Swami, Umang
Thompson, John A.
Vikas, Praveen
Wang, Yinghong
Weber, Jeffrey S.
Funchain, Pauline
Bollin, Kathryn
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4073 - +
[45] Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
Duraisamy, Prasanna
Panicker, Vinitha Varghese
Jose, Wesley Mannirathil
DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
[46] Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
Inoue, Yusuke
Inui, Naoki
INTERNAL MEDICINE, 2024,
[47] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
Aude, C.
Ghosh, N.
Jannat-Khah, D.
Chan, K. K.
Postow, M.
Larman, H.
Bass, A.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
[48] Immune signatures of treatment response and immune-related adverse events in melanoma patients under checkpoint inhibitor therapy
Reschke, R.
Gussek, P.
Boldt, A.
Sack, U.
Koehl, U.
Lordick, F.
Kreuz, M.
Reiche, K.
Simon, J. C.
Ziemer, M.
Kunz, M.
EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E57 - E57
[49] Neurologic Adverse Events associated with Immune Checkpoint Inhibitor Therapy
Duong, Sophie Lan-Linh
Barbiero, Frank J.
Huttner, Anita
Nowak, Richard J.
Baehring, Joachim J.
NEUROLOGY, 2019, 92 (15)
[50] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Dolladille, Charles
Ederhy, Stephane
Sassier, Marion
Cautela, Jennifer
Thuny, Franck
Cohen, Ariel A.
Fedrizzi, Sophie
Chretien, Basile
Da-Silva, Angelique
Plane, Anne-Flore
Legallois, Damien
Milliez, Paul U.
Lelong-Boulouard, Veronique
Alexandre, Joachim
JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871

← 1 2 3 4 5 →